BCLSI
Bain Capital Life Sciences Investors Portfolio holdings
AUM
$799M
1-Year Return
36.47%
This Quarter Return
+32.52%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$971M
AUM Growth
+$171M
(+21%)
Cap. Flow
+$12.8M
Cap. Flow
% of AUM
1.32%
Top 10 Holdings %
Top 10 Hldgs %
68.82%
Holding
35
New
1
Increased
4
Reduced
3
Closed
3
Top Buys
| 1 |
NewAmsterdam Pharma
NAMS
|
+$25.8M |
| 2 |
Cabaletta Bio
CABA
|
+$25.8M |
| 3 |
Pharvaris
PHVS
|
+$25.6M |
| 4 |
X4 Pharmaceuticals
XFOR
|
+$7.29M |
| 5 |
Annexon
ANNX
|
+$2.87M |
Top Sells
| 1 |
Disc Medicine
IRON
|
+$29.2M |
| 2 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
+$19.8M |
| 3 |
Dynavax Technologies
DVAX
|
+$19.4M |
| 4 |
TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
|
+$3.59M |
| 5 |
Spyre Therapeutics
SYRE
|
+$1.55M |
Sector Composition
| 1 | Healthcare | 98.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SYRS
26
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $6.69M | 0.69% |
2,124,694
| – | – |
|
27
Tango Therapeutics
TNGX
$727M
| $6.38M | 0.66% |
1,921,790
| – | – |
|
28
C4 Therapeutics
CCCC
$189M
| $4.52M | 0.47% |
1,642,210
| – | – |
|
|
THRD
29
DELISTED
Third Harmonic Bio
THRD
| $3.08M | 0.32% |
640,631
| – | – |
|
|
TVRD
30
Tvardi Therapeutics, Inc. Common Stock
TVRD
$318M
| $2.65M | 0.27% |
25,969
-35,266
| -58% | -$3.59M |
|
31
Invivyd
IVVD
$299M
| $2.03M | 0.21% |
1,937,207
| – | – |
|
|
32
NewAmsterdam Pharma Company N.V. Warrant
NAMSW
$62.3M
| $209K | 0.02% |
100,000
| – | – |
|
|
33
Spyre Therapeutics
SYRE
$945M
| – | – |
-213,908
| Closed | -$1.55M |
|
|
APTX
34
DELISTED
Aptinyx Inc. Common Stock
APTX
| – | – |
-8,891,758
| Closed | -$1.11M |
|
|
CTIC
35
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| – | – |
-4,702,996
| Closed | -$19.8M |
|